Cicada Innovations

Cicada Innovations announced the 2026 cohort of 23 Australian deep tech startups selected from 230+ applications, spanning energy, health, space, defence, agriculture, manufacturing and AI. Cohort includes companies developing thermal batteries, AI on edge hardware, solar surface technology, robotics, and medical diagnostics.

Leadership read: Cicada selecting 23 companies from 230-plus applications is not the headline; the record application volume is. A 10:1 rejection ratio from a field spanning seven distinct verticals means the pipeline of credible Australian deep-tech ventures has outgrown the infrastructure that was built to serve it. The cohort companies are now committed to a structured commercialisation pathway, investor exposure, policy access, and peer cohort accountability, before most of them have revenue. That is the operating bet: science-stage companies absorbing a commercial-readiness programme simultaneously. This sits in a thin but directionally consistent pattern. Of the 12 related signals we have tracked in the last 90 days, the most relevant are TotalEnergies' Hydra solar-plus-storage inauguration in South Africa and L&T's in-house semiconductor build, both pointing to capital and capability concentrating around hard-science infrastructure rather than software-layer plays. The European H1 2026 data reinforces the directional shift: AI, healthtech, and energy collectively absorbed the majority of concentrated capital even as deal count fell. Cicada's cohort, thermal batteries, edge AI, space recovery, cancer therapeutics, maps precisely onto that concentration. Companies at this stage of deep-tech commercialisation, pre-revenue, post-validation, entering structured market exposure, consistently surface demand for commercial leadership with dual fluency in science translation and enterprise sales, regulatory and export-compliance capability across energy and medical device corridors, and partnership operations that can connect sovereign-funded R&D to industrial buyers. The market is moving toward operators who can compress the distance between laboratory proof and procurement-ready product.

curated · 2026-07-02 · context →

Cicada Innovations accepting applications for annual deep tech accelerator program selecting 23 ventures, indicating expansion of portfolio support activities

Leadership read: Cicada x Tech23 selecting 23 ventures annually is not a passive curation exercise, it commits the organisation to active portfolio stewardship across a cohort with genuinely heterogeneous technical and commercial maturity. Running 23 deep tech companies through a structured program simultaneously creates internal pressure on program delivery, venture assessment methodology, and the translation of frontier science into fundable commercial theses. That is a materially different operating load than a smaller or less codified intake, and it demands program infrastructure built around sector expertise, not generalist acceleration. The related signals provided are a loose set of strategic hires across fintech, hospitality, law, and defence, with no direct comparables in ANZ deep tech program management or accelerator expansion. Honest assessment: the pattern density here is thin for this specific corridor. The 12 signals are drawn from unrelated sectors and geographies and do not constitute a coherent market pattern against which to benchmark Cicada's move. What the signal does surface independently is a functional demand pattern visible across ANZ's maturing deep tech infrastructure, program leadership with genuine domain depth in hard-science commercialisation, venture assessment capability that goes beyond pitch-day scoring, and the corporate partnerships and capital-market relationships that convert accelerator alumni into funded, scaling businesses. The market is moving toward operators who can hold both scientific credibility and commercial architecture simultaneously.

curated · 2026-04-21 · context →